Paper4421998
Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.
Almon RR and 2 others. Science, 1974. Cited by 374 papers, by iCite.
Cite this record
ConductScience Library. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Papers, record 4421998. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4421998
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bungarotoxins | Major topic |
| Myasthenia Gravis | Major topic |
| Neuromuscular Junction | Major topic |
| Receptors, Cholinergic | Major topic |
| Serum Globulins | Major topic |
| Acetylcholine | |
| Adult | |
| Aged | |
| Animals | |
| Binding Sites | |
| Binding, Competitive | |
| Female | |
| Humans | |
| Iodine Radioisotopes | |
| Male | |
| Middle Aged | |
| Rats |
Source PubMed
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 374 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42908923 | Clinical study of eculizumab with or with not tacrolimus in the treatment of generalized myasthenia gravis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42908923 | PubMed |
| 42308456 | Functional Profiling of Acetylcholine Receptor Antibodies Informs Therapeutic Outcome of FcRn Inhibitor Therapy in Myasthenia Gravis. | Neurol Neuroimmunol Neuroinflamm | 2026 | https://conductscience.org/library/papers/42308456 | PubMed |
| 42242900 | Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimod. | J Neurol Neurosurg Psychiatry | 2026 | https://conductscience.org/library/papers/42242900 | PubMed |
| 42155846 | Novel methods for neural IgG characterization and validation in autoimmune neurologic disorders. | J Immunol Methods | 2026 | https://conductscience.org/library/papers/42155846 | PubMed |
| 41118207 | Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/41118207 | PubMed |
| 40680247 | AChR Autoantibody Pathogenic Properties Are Heterogeneously Distributed and Undergo Temporal Changes Among Patients With Myasthenia Gravis. | Neurol Neuroimmunol Neuroinflamm | 2025 | https://conductscience.org/library/papers/40680247 | PubMed |
| 40303417 | The role of complement in the immunopathogenesis of acetylcholine receptor antibody-positive generalized myasthenia gravis: bystander or key player? | Front Immunol | 2025 | https://conductscience.org/library/papers/40303417 | PubMed |
| 39987373 | Myasthenia gravis in 2025: five new things and four hopes for the future. | J Neurol | 2025 | https://conductscience.org/library/papers/39987373 | PubMed |
| 38133144 | Pathophysiology of Childhood-Onset Myasthenia: Abnormalities of Neuromuscular Junction and Autoimmunity and Its Background. | Pathophysiology | 2023 | https://conductscience.org/library/papers/38133144 | PubMed |
| 37817097 | Female sex and overweight are associated with a lower quality of life in patients with myasthenia gravis: a single center cohort study. | BMC Neurol | 2023 | https://conductscience.org/library/papers/37817097 | PubMed |
| 35290370 | Myasthenia gravis complement activity is independent of autoantibody titer and disease severity. | PLoS One | 2022 | https://conductscience.org/library/papers/35290370 | PubMed |
| 34784297 | Protease-dependent defects in N-cadherin processing drive PMM2-CDG pathogenesis. | JCI Insight | 2021 | https://conductscience.org/library/papers/34784297 | PubMed |
| 33365280 | Complement Inhibition for the Treatment of Myasthenia Gravis. | Immunotargets Ther | 2020 | https://conductscience.org/library/papers/33365280 | PubMed |
| 33199596 | Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/33199596 | PubMed |
| 32547535 | Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology. | Front Immunol | 2020 | https://conductscience.org/library/papers/32547535 | PubMed |
| 31482201 | Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review. | J Neurol | 2021 | https://conductscience.org/library/papers/31482201 | PubMed |
| 28940642 | B cells in the pathophysiology of myasthenia gravis. | Muscle Nerve | 2018 | https://conductscience.org/library/papers/28940642 | PubMed |
| 28761905 | Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity. | Neurol Neuroimmunol Neuroinflamm | 2017 | https://conductscience.org/library/papers/28761905 | PubMed |
| 27127487 | "Warming yang and invigorating qi" acupuncture alters acetylcholine receptor expression in the neuromuscular junction of rats with experimental autoimmune myasthenia gravis. | Neural Regen Res | 2016 | https://conductscience.org/library/papers/27127487 | PubMed |
| 26136751 | Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases. | Front Immunol | 2015 | https://conductscience.org/library/papers/26136751 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4421998
GET https://conductscience.org/api/papers/v1/4421998/cited_by?page=2